Publications by authors named "Jennifer D Guo"

Claim this Profile
P
Pragmatic paradigm for patient-reported outcome measure selection in lymphoma clinical trials: a rapid review study.
Jennifer D Guo, Abraham Hartzema, Jonathon B Cohen, Nicole Tunstall, Adel Gehchan

BMJ Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of indirect treatment comparisons for health technology assessments: a practical guide for health economics and outcomes research scientists and clinicians.
Jennifer D Guo, Adel Gehchan, Abraham Hartzema

BMJ Open· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends in anticoagulation use and clinical outcomes among medicare beneficiaries with non-valvular atrial fibrillation.
Brett D Atwater, Jennifer D Guo, Allison Keshishian, Rachel Delinger, Cristina Russ

J Thromb Thrombolysis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic variation in clinical outcomes and anticoagulation among medicare beneficiaries with non-valvular atrial fibrillation.
Brett D Atwater, Manuela Di Fusco, Allison Keshishian, Rachel Delinger, Mauricio Ferri, Jennifer D Guo

J Thromb Thrombolysis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States.
Mintu P Turakhia, Jennifer D Guo, Allison Keshishian, Rachel Delinger, Xiaoxi Sun

Clin Cardiol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticoagulant underutilization among elderly patients with atrial fibrillation: insights from the United States Medicare database.
Muhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, Jennifer D Guo, Rajesh Mallampati

J Interv Card Electrophysiol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration.
Natasha Din, Jun Fan, Susan Schmitt, Jennifer D Guo, Patrick Hlavacek

Clin Appl Thromb Hemost· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
Muhammad Bilal Munir, Patrick Hlavacek, Allison Keshishian, Jennifer D Guo, Rajesh Mallampati

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The burden of undertreatment and non-treatment among patients with non-valvular atrial fibrillation and elevated stroke risk: a systematic review.
Matthew Sussman, Geoffrey D Barnes, Jennifer D Guo, Charles Y Tao, John A Gillespie

Curr Med Res Opin· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anticoagulation Treatment and Outcomes of Venous Thromboembolism by Weight and Body Mass Index: Insights From the Veterans Health Administration.
Alexander C Perino, Jun Fan, Susan Schmitt, Jennifer D Guo, Patrick Hlavacek

Circ Cardiovasc Qual Outcomes· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IMPact of untReated nOn-Valvular atrial fibrillation on short-tErm clinical and economic outcomes in the US Medicare population: the IMPROVE-AF model.
Matthew Sussman, Manuela Di Fusco, Charles Y Tao, Jennifer D Guo, John A Gillespie

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and effectiveness of apixaban compared with warfarin among clinically-relevant subgroups of venous thromboembolism patients in the United States Medicare population.
Jennifer D Guo, Patrick Hlavacek, Lisa Rosenblatt, Allison Keshishian, Cristina Russ

Thromb Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and treatment patterns of patients with venous thromboembolism (VTE) transitioning from hospital to post-discharge settings.
Tanya Burton, Patrick Hlavacek, Jennifer D Guo, Lisa Rosenblatt, Jack Mardekian

Hosp Pract (1995)· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database.
Jennifer D Guo, Jigar Rajpura, Patrick Hlavacek, Allison Keshishian, Janvi Sah

J Manag Care Spec Pharm· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of alemtuzumab on health-related quality of life over 6 years in CARE-MS II trial extension patients with relapsing-remitting multiple sclerosis.
Rafael Arroyo, Denise P Bury, Jennifer D Guo, David H Margolin, Maria Melanson

Mult Scler· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of inpatient admission rates of patients treated with apixaban vs. warfarin for venous thromboembolism in the emergency department.
Steven Deitelzweig, Patrick Hlavacek, Jack Mardekian, Lisa Rosenblatt, Cristina Russ, Jennifer D Guo

Hosp Pract (1995)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding and recurrent VTE with apixaban vs warfarin as outpatient treatment: time-course and subgroup analyses.
Derek Weycker, Gail DeVecchis Wygant, Jennifer D Guo, Theodore Lee, Xuemei Luo

Blood Adv· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population.
Patrick Hlavacek, Jennifer D Guo, Lisa Rosenblatt, Allison Keshishian, Cristina Russ

Curr Med Res Opin· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hospital Resource Utilization and Costs Associated With Warfarin Versus Apixaban Treatment Among Patients Hospitalized for Venous Thromboembolism in the United States.
Steven Deitelzweig, Jennifer D Guo, Patrick Hlavacek, Jay Lin, Gail Wygant

Clin Appl Thromb Hemost· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Meta-analysis of safety for low event-rate binomial trials.
Jonathan J Shuster, Jennifer D Guo, Jay S Skyler

Res Synth Methods· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
Jennifer D Guo, Gordon G Liu, Dale B Christensen, Alex Z Fu

Value Health· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis